Physician profile
Ellen E Lee
NPI 1184859811
$836.90
in general payments reported to CMS, 2019-2025
11 companies · $101 in 2025
The $101 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.81 · 2020: $131 · 2021: $168 · 2022: $114 · 2023: $193 · 2024: $110 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteocentric Technologies, INC. | $165.58 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Medtronic Vascular, INC. | $130.74 | 2020 | |
| Spr Therapeutics, INC | $114.47 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $101.07 | 2025 | |
| Abiomed | $92.35 | 2021 | |
| Medtronic, INC. | $75.92 | 2021 | |
| Fisher & Paykel Healthcare INC | $58.60 | 2024 | Fisher & Paykel Healthcare |
| Ambu INC. | $35.58 | 2024 | |
| Eagle Pharmaceuticals, INC. | $27.65 | 2023 | |
| Lundbeck LLC | $18.81 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.13 | 2024 | Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.